Emerging Company Profile
OnCusp: Bing Yuan’s newco to provide bridge from innovation to MNC
Emerging Company Profile: OnCusp launches to license, develop early stage cancer therapies before out-licensing assets to MNCs
OnCusp launches to license and develop early stage cancer therapies sourced in the U.S. and China, aiming to reach POC before out-licensing to MNCs.
Jul 2, 2021 | 1:34 AM GMT
Former CStone and Merck & Co. dealmaker Bing Yuan and his OnCusp co-founders are using their early stage drug hunting skills to